Yegah Musicology Journal, cilt.8, sa.2, ss.693-716, 2025 (Scopus)
Music therapy is increasingly recognized as a non-invasive and interdisciplinary approach offering potential benefits for various neurological conditions. This study aims to synthesize findings from existing clinical research to evaluate the effects of music-based interventions on Parkinson’s disease, Alzheimer’s disease, and Autism Spectrum Disorder (ASD). The primary objective is to systematically analyze the cognitive, emotional, and physical outcomes associated with music therapy in these disorders, and to explore the underlying therapeutic mechanisms. Furthermore, the study discusses how music interventions may complement traditional medical treatments and identifies existing limitations in the field. The findings suggest that music therapy enhances functional outcomes by engaging neuroplasticity, emotional responsiveness, and rhythmic synchronization. In Parkinson’s disease, Rhythmic Auditory Stimulation (RAS) improves motor coordination, gait stability, and balance. In Alzheimer’s disease, music supports memory recall, emotional regulation, and reduces caregiver burden. In individuals with ASD, participatory music activities are associated with improvements in social interaction, emotional regulation, and sensory integration. Although music therapy shows promise as a complementary intervention, challenges such as small sample sizes, methodological variability, and lack of standardized protocols are noted. Future research should prioritize longitudinal studies and the development of AI-assisted, culturally adaptive interventions. Given its interdisciplinary foundation, music therapy holds significant potential for enhancing holistic management of neurological and neurodevelopmental disorders.